Skip to main content
. 2020 Nov 23;124(4):786–796. doi: 10.1038/s41416-020-01168-x

Fig. 1. GMS can stratify recurrence and survival according to disease risk in the validation cohort.

Fig. 1

ac Kaplan–Meier curve showing associations between GMS and DFS in the a full cohort (n = 862), b “low-risk” colorectal cancer (n = 499) and c “high-risk” colorectal cancer (n = 363). de Kaplan–Meier curve showing associations between GMS and RFS in the a full cohort (n = 862), b “low-risk” colorectal cancer (n = 499) and c “high-risk” colorectal cancer (n = 363).